Clear Targets In Pediatric Atopic Dermatitis
A Case-Based Update
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis.
Kong HH, et al. Genome Res. 2012;22(5):850-859.
Identification of atopic dermatitis subgroups in children from 2 longitudinal birth cohorts.
Paternoster L, et al. J Allergy Clin Immunol. 2018:141(3):964-971.
Pathogenesis of atopic dermatitis.
Peng W, Novak N. Clin Exp Allergy. 2015;45(3):566-574.
Patient Burden and Comorbidities
The price of pruritus: sleep disturbance and cosleeping in atopic dermatitis.
Chamlin SL, et at. Arch Pediatr Adolesc Med. 2005;159(8):745-750.
Bidirectional relationships between psychological health and dermatological conditions in children.
Mitchell AE. Psychol Res Behav Manag. 2018;11:289-298.
Association of inadequately controlled disease and disease severity with patient-reported disease burden in adults with atopic dermatitis.
Simpson EL, et al. JAMA Dermatol. 2018;154(8):903-912.
Mental health comorbidity in patients with atopic dermatitis.
Yaghmaie P, et al. J Allergy Clin Immunol. 2013;131(2):428-433.
Management of Atopic Dermatitis
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
Blauvelt A, et al. Lancet. 2017;389(10086):2287-2303.
Atopic dermatitis yardstick: practical recommendations for an evolving therapeutic landscape.
Boguniewicz M, et al. Ann Allergy Asthma Immunol. 2018;120(1):10-22.e2.
Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.
Drucker AM, et al. Br J Dermatol. 2018;178(3):768-775.
Translating atopic dermatitis management guidelines into practice for primary care providers.
Eichenfield LF, et al. Pediatrics. 2015;136(3):554-565.
Application of moisturizer to neonates prevents development of atopic dermatitis.
Horimukai K, et al. J Allergy Clin Immunol. 2014;134(4):824-830.e6.
Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity.
Huang JT, et al. Pediatrics. 2009;123(5):e808-e814.
Anti-interleukin-31 receptor A antibody for atopic dermatitis.
Ruzicka T, et al. N Engl J Med. 2017;376(9):826-835.
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council.
Simpson EL, et al. J Am Acad Dermatol. 2017;77(4):623-633.
Two phase 3 trials of dupilumab versus placebo in atopic dermatitis.
Simpson EL, et al. N Engl J Med. 2016;375(24):2335-2348.
Guidelines
Guidelines of care for the management of atopic dermatitis: part 1. Diagnosis and assessment of atopic dermatitis.
Eichenfield LF, et al. J Am Acad Dermatol. 2014;70(2):338-351.
Guidelines of care for the management of atopic dermatitis: part 2. Management and treatment of atopic dermatitis with topical therapies.
Eichenfield LF, et al. J Am Acad Dermatol. 2014;71(1):116-132.
Guidelines of care for the management of atopic dermatitis: part 3. Management and treatment with phototherapy and systemic agents.
Sidbury R, et al. J Am Acad Dermatol. 2014;71(2):327-349.
Guidelines of care for the management of atopic dermatitis: part 4. Prevention of disease flares and use of adjunctive therapies and approaches.
Sidbury R, et al. J Am Acad Dermatol. 2014;71(6):1218-1233.
Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I.
Wollenberg A, et al. J Eur Acad Dermatol Venereol. 2018;32(5):657-682.
Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II.
Wollenberg A, et al. J Eur Acad Dermatol Venereol. 2018;32(6):850-878.
Patient Resources
Patient Handout: Helping Your Pediatric and Their Families Understand Systemic Therapy for Moderate-to-Severe Atopic Dermatitis
The Society for Pediatric Dermatology
Established in 1975, the Society for Pediatric Dermatology provides resources for patients and families to help them with dermatologic issues.
International Eczema Council
Founded in late 2014, the International Eczema Council (IEC) is a global nonprofit organization led by dermatology experts on atopic dermatitis. The IEC is dedicated to increasing the understanding of atopic dermatitis and promoting its optimal management through research, education, and patient/family care.
National Eczema Association
The National Eczema Association is a nonprofit organization founded in 1988 to improve the health and quality of life for individuals with eczema through research, support, and education.
Clinical Assessment Tools
Children’s Dermatology Life Quality Index (CDLQI)
The CDLQI is 10-question patient-reported assessment tool designed to measure impact of any skin disease on the lives of children aged 4-16 years. (Lewis-Jones MS, Finlay AY. Br J Dermatol. 1995;132(6):942-949).
Eczema Area and Severity Index (EASI)
The EASI is a clinician assessment tool designed to measure clinical severity of atopic dermatitis. Severity scores can range from 0 (clear) to 72 (very severe). (Hanifin JM, et al. Exp Dermatol. 2001;10(1):11-18).
Investigator Global Assessment (IGA)
The IGA is a clinician assessment strategy designed to provide a snapshot of overall disease severity in dermatologic clinical trials. (Futamura M, et al. J Am Acad Dermatol. 2016;74(2):288-294).
Patient-Oriented Eczema Measure (POEM)
The POEM is a patient-oriented, self-assessment measurement tool for monitoring aspects of atopic dermatitis in routine clinical practice or in the clinical trial setting. (Charman CR, et al. Arch Dermatol. 2004;140(12):1513-1519).
Scoring Atopic Dermatitis (SCORAD)
SCORAD is a clinical tool used to assess the extent and severity of eczema. (Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186(1):23-31.)
Clear Targets in Pediatric Atopic Dermatitis
A Case-Based Update
| Faculty: | Peter A. Lio, MD; Corinna Rea, MD, MPH; Anne Marie Singh, MD |
| Release: | 12/08/2021 |
| Expiration: | 12/08/2022 |
